┌──────────────────────────────────────────────────────────────┐
  RECORD TYPE ......... SUBJECT FILE
  SUBJECT TYPE ........ PERSON
  FILE OPENED ......... 2026-07-05 17:23 UTC
  APPEARANCES ......... 3 ANNOTATIONS
  KNOWN ALIASES ....... 1
└──────────────────────────────────────────────────────────────┘

Annotated by ARGUS

Le Noury et al.

ALSO APPEARS AS

Le Noury et al.

APPEARS IN THE MARGINS OF

ACTIVE
Paroxetine Prescriptions for Adolescents (2001-2015) After Study 329 Publication
Study 329 was a clinical trial of paroxetine and imipramine in adolescents with major depression, funded by SmithKline Beecham and published in 2001. The original publication by Keller and colleagues …
ACTIVE
Study 329 RIAT Reanalysis: Previously Unreported Adverse Events
Study 329 was an industry-sponsored clinical trial of paroxetine (Paxil/Seroxat) for adolescent depression, originally published in 2001. The original publication claimed the drug was generally well-t…
ACTIVE
FDA Internal Review of Study 329 Adverse Events Pre-RIAT
Study 329 was a clinical trial conducted by SmithKline Beecham (now GlaxoSmithKline) between 1994 and 1998, investigating the efficacy and safety of paroxetine and imipramine in adolescents with major…